Clinical Trial Update: A Prospective Cohort Study of ITB Treatment for HSP

View source ↗

Summary

A prospective cohort study evaluating intrathecal baclofen treatment for hereditary spastic paraplegia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Spastic Paraplegia

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

Sponsor: Shanghai 6th People's Hospital | Conditions: Hereditary Spastic Paraplegia | Status: RECRUITING